NIH-funded research R15 grant

Understanding how certain proteins help prevent genomic instability

Official title: XRN2-DDX23 Cooperation in Avoiding R-loop-induced Genomic Instability

Funded at New Mexico Inst of Mining & Technology · NIH-10654331 · Data updated 2026-11-12

This study is looking at how two proteins, XRN2 and DDX23, help keep our DNA stable and healthy by stopping harmful structures that can lead to diseases like cancer and autoimmune disorders, with the hope of finding new ways to help people who have these conditions.

Quick facts

Grant typeR15 grant
Study typeNIH-funded research
Funding institutionNew Mexico Inst of Mining & Technology
NIH-funded
Lab location1 site (Socorro, United States)
Project startAugust 18, 2023
Project endJuly 31, 2026
Funding year2023
Award (this year)$355,584
NIH project number1R15GM150071-01
Project IDNIH-10654331 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals with autoimmune diseases or cancers that may be linked to genomic instability.

Less likely to help

Patients with conditions unrelated to genomic instability or those not affected by autoimmune diseases or cancers may not benefit from this research.

What this research studies

This research investigates the roles of specific proteins, XRN2 and DDX23, in maintaining genomic stability by preventing harmful structures called R-loops that can lead to diseases like cancer and autoimmune disorders. The study aims to explore how these proteins interact and contribute to DNA repair and cell survival. By understanding these mechanisms, the research seeks to identify potential therapeutic targets for improving health outcomes in patients affected by genomic instability-related conditions.

Why it matters

Potential benefit: If successful, this research could lead to new treatments that enhance DNA repair mechanisms, potentially reducing the risk of diseases like cancer and autoimmune disorders.

How similar studies have gone: Other research has shown promising results in understanding the roles of proteins in DNA repair, suggesting that this approach could yield valuable insights.

Where this research is happening

  • New Mexico Inst of Mining & Technology
    Socorro, United States
    Active

Researchers

  • Principal investigator: Patidar, Praveen — New Mexico Inst of Mining & Technology
  • Study coordinator: Patidar, Praveen

Related research

Other NIH-funded projects on the same topics.

  • Smart mine evacuation and rescue system

    This project will build and demonstrate a smart evacuation and rescue system to help miners and rescue teams find and reach people faster during underground emergencies.

    NIH research New Mexico Inst of Mining & Technology · Socorro, United States · NIH-11419437

  • Creating a smart system for mine evacuation and rescue.

    This study is working on a smart system to help keep miners safe during emergencies by quickly figuring out the best ways to guide them to safety when they need to evacuate or get rescued.

    NIH research New Mexico Inst of Mining & Technology · Socorro, United States · NIH-11142299

  • Creating smart systems to help evacuate and rescue miners in emergencies

    This study is all about creating smart robots and technology to help keep miners safe during emergencies, making it easier for them and rescue teams to find their way out of dangerous situations.

    NIH research New Mexico Inst of Mining & Technology · Socorro, United States · NIH-10831375

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.